Rallybio (RLYB) EBITDA Margin (2024 - 2026)
Rallybio (RLYB) posted EBITDA Margin of 4119.34% for Q1 2026, down 42.62% sequentially from 2888.29% in Q4 2025, and up 44198.0% YoY from N/an in Q1 2025.
Rallybio (RLYB) EBITDA Margin (2024 - 2026) Analysis & Trends
Rallybio has reported EBITDA Margin for 3 years, with the latest figure at 4119.34% in Q1 2026.
- Quarterly EBITDA Margin rose 44198.0% year-over-year to 4119.34% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3744.41% (up 219651.0% YoY) and the FY2025 annual result came in at 3853.61%, up 565834.0% from the prior year.
- EBITDA Margin declined to 4119.34% in Q1 2026 per RLYB's latest filing, from 2888.29% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2888.29% in Q4 2025 and troughed at 30547.37% in Q4 2024.
- A 3-year average of 7482.43% and a median of 4340.33% in 2026 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin jumped 2765908 bps in 2025, then jumped 44198 bps in 2026.
- Over 3 years, EBITDA Margin stood at 30547.37% in 2024, then jumped by 91 bps to 2888.29% in 2025, then tumbled by 43 bps to 4119.34% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 4119.34%, 2888.29%, and 3266.51% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.75% |
| 10 | Rallybio | 94.32 Mn | 94.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,119.34% |
| Dec 31, 2025 | -2,888.29% |
| Sep 30, 2025 | -3,266.51% |
| Jun 30, 2025 | -4,743.87% |
| Mar 31, 2025 | -4,561.32% |
| Dec 31, 2024 | -30,547.37% |
| Sep 30, 2024 | -4,035.45% |
| Jun 30, 2024 | -5,697.32% |